These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 24082692)
1. Recent advance technique for ocular drug delivery by Gupta et al.: Nanoparticle laden in situ gel. Gupta P; Kumar M J Pharm Bioallied Sci; 2013 Jul; 5(3):175. PubMed ID: 24082692 [No Abstract] [Full Text] [Related]
2. Nanoparticles laden in situ gel for sustained ocular drug delivery. Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G J Pharm Bioallied Sci; 2013 Apr; 5(2):162-5. PubMed ID: 23833523 [TBL] [Abstract][Full Text] [Related]
3. Nanoparticles laden in situ gel of levofloxacin for enhanced ocular retention. Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G Drug Deliv; 2013; 20(7):306-9. PubMed ID: 24044648 [TBL] [Abstract][Full Text] [Related]
4. Nanoparticles laden in situ gelling system for ocular drug targeting. Kumar D; Jain N; Gulati N; Nagaich U J Adv Pharm Technol Res; 2013 Jan; 4(1):9-17. PubMed ID: 23662277 [TBL] [Abstract][Full Text] [Related]
5. Polysaccharide as renewable responsive biopolymer for in situ gel in the delivery of drug through ocular route. Chowhan A; Giri TK Int J Biol Macromol; 2020 May; 150():559-572. PubMed ID: 32057864 [TBL] [Abstract][Full Text] [Related]
6. Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer. Katz H; Wassie E; Alsharedi M Med Oncol; 2017 Sep; 34(10):170. PubMed ID: 28864844 [TBL] [Abstract][Full Text] [Related]
7. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease. Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738 [TBL] [Abstract][Full Text] [Related]
8. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone. Wen Y; Ban J; Mo Z; Zhang Y; An P; Liu L; Xie Q; Du Y; Xie B; Zhan X; Tan L; Chen Y; Lu Z Nanotechnology; 2018 Oct; 29(42):425101. PubMed ID: 30074486 [TBL] [Abstract][Full Text] [Related]
9. Fluconazole nanoparticles prepared by antisolvent precipitation technique: Physicochemical, El Sayeh F Abou El Ela A; Abbas Ibrahim M; Alqahtani Y; Almomen A; Sfouq Aleanizy F Saudi Pharm J; 2021 Jun; 29(6):576-585. PubMed ID: 34194264 [TBL] [Abstract][Full Text] [Related]
11. A stimulus-responsive, in situ-forming, nanoparticle-laden hydrogel for ocular drug delivery. Kabiri M; Kamal SH; Pawar SV; Roy PR; Derakhshandeh M; Kumar U; Hatzikiriakos SG; Hossain S; Yadav VG Drug Deliv Transl Res; 2018 Jun; 8(3):484-495. PubMed ID: 29508159 [TBL] [Abstract][Full Text] [Related]
12. In situ assembly of antifouling/bacterial silver nanoparticle-hydrogel composites with controlled particle release and matrix softening. Baek K; Liang J; Lim WT; Zhao H; Kim DH; Kong H ACS Appl Mater Interfaces; 2015 Jul; 7(28):15359-67. PubMed ID: 26046485 [TBL] [Abstract][Full Text] [Related]
13. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution. Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932 [TBL] [Abstract][Full Text] [Related]
14. Research progress of in-situ gelling ophthalmic drug delivery system. Wu Y; Liu Y; Li X; Kebebe D; Zhang B; Ren J; Lu J; Li J; Du S; Liu Z Asian J Pharm Sci; 2019 Jan; 14(1):1-15. PubMed ID: 32104434 [TBL] [Abstract][Full Text] [Related]
15. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies. Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418 [TBL] [Abstract][Full Text] [Related]
16. Endotherapy for bile leaks from isolated ducts after hepatic resection: A long awaited challenge. Mutignani M; Forti E; Dokas S; Pugliese F; Fontana P; Tringali A; Dioscoridi L Dig Liver Dis; 2017 Aug; 49(8):893-897. PubMed ID: 28457903 [TBL] [Abstract][Full Text] [Related]
17. Advances and limitations of drug delivery systems formulated as eye drops. Jumelle C; Gholizadeh S; Annabi N; Dana R J Control Release; 2020 May; 321():1-22. PubMed ID: 32027938 [TBL] [Abstract][Full Text] [Related]
18. Advances and challenges in the nanoparticles-laden contact lenses for ocular drug delivery. Maulvi FA; Desai DT; Shetty KH; Shah DO; Willcox MDP Int J Pharm; 2021 Oct; 608():121090. PubMed ID: 34530102 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-Laden Contact Lens for Controlled Ocular Delivery of Prednisolone: Formulation Optimization Using Statistical Experimental Design. ElShaer A; Mustafa S; Kasar M; Thapa S; Ghatora B; Alany RG Pharmaceutics; 2016 Apr; 8(2):. PubMed ID: 27104555 [TBL] [Abstract][Full Text] [Related]
20. Extended release of ketotifen from silica shell nanoparticle-laden hydrogel contact lenses: in vitro and in vivo evaluation. Maulvi FA; Mangukiya MA; Patel PA; Vaidya RJ; Koli AR; Ranch KM; Shah DO J Mater Sci Mater Med; 2016 Jun; 27(6):113. PubMed ID: 27178036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]